FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy

被引：0
|
作者：
E. E. Fransen van de Putte
E. Vegt
L. S. Mertens
A. Bruining
K. Hendricksen
M. S. van der Heijden
S. Horenblas
B. W. G. van Rhijn
机构：
[1] The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital,Department of Urology
[2] The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital,Department of Nuclear Medicine
[3] The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital,Department of Radiology
[4] The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital,Department of Medical Oncology
来源：
International Urology and Nephrology | 2017年 / 49卷
关键词：
Urinary bladder neoplasms; Positron emission tomography; Fluorodeoxyglucose F18; Chemotherapy; Metabolic response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1585 / 1591
页数：6
相关论文
共 50 条
  • [21] FDG PET/CT for monitoring response to neoadjuvant chemotherapy in breast cancer patients
    Katharina Dalus
    Gundula Rendl
    Lukas Rettenbacher
    Christian Pirich
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1992 - 1993
  • [22] FDG PET/CT for monitoring response to neoadjuvant chemotherapy in breast cancer patients
    Dalus, Katharina
    Rendl, Gundula
    Rettenbacher, Lukas
    Pirich, Christian
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (10) : 1992 - 1993
  • [23] A role of FDG-PET/CT for response evaluation in metastatic breast cancer?
    Hildebrandt, Malene Grubbe
    Naghavi-Behzad, Mohammad
    Vogsen, Marianne
    SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (05) : 520 - 530
  • [24] Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting
    David Groheux
    Gary A. Ulaner
    Elif Hindie
    Clinical and Translational Imaging, 2023, 11 : 439 - 452
  • [25] Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting
    Groheux, David
    Ulaner, Gary A.
    Hindie, Elif
    CLINICAL AND TRANSLATIONAL IMAGING, 2023, 11 (05) : 439 - 452
  • [26] FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients: initial results
    Buchbender, Christian
    Kuemmel, Sherko
    Hoffmann, Oliver
    Stahl, Alexander R.
    Kimmig, Rainer
    Otterbach, Friedrich
    Ladd, Susanne
    Koeninger, Angela
    Forsting, Michael
    Bockisch, Andreas
    Antoch, Gerald
    Heusner, Till A.
    ACTA RADIOLOGICA, 2012, 53 (06) : 628 - 636
  • [27] Response evaluation of Neoadjuvant therapy in esophageal squamous cell cancer: Comparison of CT-volumetry and FDG-PET
    Ruell, T
    Brosow, R
    Raeth, CW
    Bruegel, M
    Weber, W
    Link, TM
    RADIOLOGY, 2002, 225 : 581 - 581
  • [28] FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies
    Sheikhbahaei, Sara
    Trahan, Tyler J.
    Xiao, Jennifer
    Taghipour, Mehdi
    Mena, Esther
    Connolly, Roisin M.
    Subramaniam, Rathan M.
    ONCOLOGIST, 2016, 21 (08): : 931 - 939
  • [29] Predictive Value of 18F-FDG PET/CT for Assessment of Tumor Response to Neoadjuvant Chemotherapy in Bladder Cancer
    Ko, Woo Seog
    Kim, Seong-Jang
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (07) : 574 - 580
  • [30] Sequential FDG-PET scanning in the assessment of response to neoadjuvant chemotherapy in operable esophageal cancer.
    Melcher, L
    Wong, W
    Sanghera, B
    Bentzen, SM
    Hall, M
    Chambers, J
    Townsend, E
    Fountain, N
    Harrison, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 327S - 327S
12345